As of Jan 10, 2025, Moderna, Inc.'s Discounted Cash Flow (DCF) valuation estimates its share price at N/A. This suggests it may be overvalued by (100.0%) compared to its current price of around $42.3, using a WACC of 10.8% and growth rates of 3.0%.
As of Jan 10, 2025, Moderna, Inc.'s Weighted Average Cost of Capital (WACC) is approximately 10.8%.
As of Jan 10, 2025, Moderna, Inc.'s Enterprise Value (EV) is approximately $0.0. This value reflects the company's total market capitalization plus debt, minus cash and cash equivalents, providing a comprehensive measure of its overall value in the market.